^
Association details:
Biomarker:No biomarker
Cancer:Prostate Cancer
Drug:carboplatin (Tubulin polymerization promoter) +
cabazitaxel (Microtubule inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Systemic Theraoy for M1 CRPC...Added: Cabazitaxel/carboplatin